Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 50

Sort by

Sort Order Select

Journal Articles

Low Dose Rituximab Efficiently Clears Circulating CLL Cells and Maintains Sensitivity to Antibody Dependent Cellular Phagocytosis (ADCP)

Clare B Heffernan, Charles C Chu, Jennifer E Bruno, Christine A Herne, Andrea M Baran, Ronald P Taylor, Paul M. Barr, Michael R. Elliott, Clive S Zent

Blood (2023) 142 (Supplement 1): 6548.

https://doi.org/10.1182/blood-2023-175019

Published: 2023

Journal Articles

Splenic B Cell Lymphoma Innate Immune Cells: Detection of Red Versus White Pulp Lymphoma Differences in NK Cell Populations By High-Parameter Flow Cytometry

Christine A Herne, Jennifer E Bruno, Andrea M Baran, Derick R Peterson, Audrey H Chung, Tim R Mosmann, Sally A Quataert, Andrew G Evans, Walter R Burack, Clive S Zent, Charles C Chu

Blood (2023) 142 (Supplement 1): 4392.

https://doi.org/10.1182/blood-2023-181081

Published: 2023

Journal Articles

Rituximab Induces an Inflammatory Cytokine Response with Increased IP-10 (CXCR10) in Patients with Infusion Reactions

Clive S. Zent, Jeremiah E. Moore, Paige C. Bloom, Charles C. Chu, Jennifer E. Bruno, Christine A. Herne, Andrea M Baran, Sally A. Quataert, Tim R. Mosmann, Ronald P. Taylor, Danielle S. Wallace, Michael R. Elliott, Paul M. Barr

Blood (2022) 140 (Supplement 1): 4171–4172.

https://doi.org/10.1182/blood-2022-162858

Published: 2022

Journal Articles

Innate Immune Microenvironment of Indolent B Cell Splenic Lymphomas: Role in Diagnosis and Treatment

Christine A. Herne, Jennifer E. Bruno, Andrea M Baran, Derick R. Peterson, Tim R. Mosmann, Sally A. Quataert, Andrew G Evans, Charles C. Chu, Clive S. Zent

Blood (2022) 140 (Supplement 1): 3585–3586.

https://doi.org/10.1182/blood-2022-167563

Published: 2022

Journal Articles

Rapid Tumor Debulking of Relapsed/Refractory CLL Patients By PI3Kδ Inhibition and Anti-CD20 Monoclonal Antibody Treatment

Jennifer E. Bruno, Christine A. Herne, Andrea M Baran, Karl R. VanDerMeid, Paul M. Barr, Alyssa R. Williams, Sally A. Quataert, Clive S. Zent, Charles C. Chu

Blood (2022) 140 (Supplement 1): 4121–4122.

https://doi.org/10.1182/blood-2022-169403

Published: 2022

Journal Articles

Characterizing Naked Nuclei Frequency and Movement in Primary AML Cell Culture Using an ECM-Based Model

Shireen J. Usman, Thomas Conley, Hannah E. Whitehead, Wojciech Wojciechowski, Kaye Thomas, Dan Bergstralh, Andrea M. Baran, Andrew G Evans, Yurong Gao, Charles C. Chu, Hani Awad, Jason H. Mendler, Michael W. Becker, Omar S. Aljitawi

Blood (2021) 138 (Supplement 1): 2365.

https://doi.org/10.1182/blood-2021-149645

Published: 2021

Journal Articles

Ibrutinib Off-Target Inhibition Inhibits Antibody-Dependent Cellular Phagocytosis but Not Efferocytosis of CLL Cells

Charles C. Chu, PhD, Jonathan J. Pinney, PhD, Sara K. Blick-Nitko, MS, Andrea M. Baran, MS, Derick R. Peterson, PhD, Hannah E. Whitehead, Raquel Izumi, PhD, Veerendra Munugalavadla, PhD, Paul M. Barr, MD, Karl R. VanDerMeid, BS, Michael Rusty Elliott, PhD, Clive S. Zent, MD

Blood (2020) 136 (Supplement 1): 45.

https://doi.org/10.1182/blood-2020-139483

Published: 2020

Journal Articles

Macrophage hypophagia as a mechanism of innate immune exhaustion in mAb-induced cell clearance

Jonathan J. Pinney, Fátima Rivera-Escalera, Charles C. Chu, Hannah E. Whitehead, Karl R. VanDerMeid, Ashley M. Nelson, Michelle C. Barbeau, Clive S. Zent, Michael R. Elliott

Blood (2020) 136 (18): 2065–2079.

https://doi.org/10.1182/blood.2020005571

Published: 2020

Includes: Multimedia, Supplemental data

Journal Articles

Anti-CD20 Therapy Reliance on Antibody-Dependent Cellular Phagocytosis Affects Combination Drug Choice

Charles C. Chu, PhD, Jonathan J. Pinney, MS, Karl R. VanDerMeid, BS, Raquel Izumi, PhD, Veerendra Munugalavadla, PhD, Paul M. Barr, MD, Michael Rusty Elliott, PhD, Clive S Zent, MD

Blood (2019) 134 (Supplement_1): 682.

https://doi.org/10.1182/blood-2019-124901

Published: 2019

Journal Articles

CLL Stereotyped Subset #4 Igs Acquire Binding to Viable B Lymphocyte Surfaces By Somatic Mutations, Isotype Class Switching, and with the Prerequisite of IG Self-Association

Yun Liu, MS, Rosa Catera, PhD, Chao Gao, PhD, Xiao J. Yan, MDPhD, Steven L. Allen, MD, Jonathan E. Kolitz, MD, Kanti Rai, MD, Charles C Chu, PhD, Ten Feizi, MD, Kostas Stamatopoulos, Nicholas Chiorazzi, MD

Blood (2017) 130 (Supplement 1): 58.

https://doi.org/10.1182/blood.V130.Suppl_1.58.58

Published: 2017

Journal Articles

CLL with Mutated IGHV4-34 Antigen Receptors Is Clinically Heterogeneous: Antigen Receptor Stereotypy Makes the Difference

Aliki Xochelli, Panagiotis Baliakas, Andreas Agathangelidis, Anastasia Hadzidimitriou, Lesley-Ann Sutton, Eva Minga, Eugen Tausch, MD, Xiao J. Yan, Tait D. Shanafelt, MD, Karla Plevova, PhD, Myriam Boudjogra, Davide Rossi, MD PhD, Zadie Davis, Alba Navarro, Yorick Sandberg, Fie Juhl Vojdeman, Lydia Scarfo, Niki Stavroyianni, Andrey B. Sudarikov, PhD, Silvio Veronese, Tatiana Tzenou, MD, Teodora Karan-Djurasevic, Mark Catherwood, PhD, Dirk Kienle, Maria Chatzouli, Monica Facco, MS, Jasmin Bahlo, Lone Bredo Pedersen, Larry Mansouri, Karin E Smedby, MD PhD, Charles C Chu, Véronique Giudicelli, Marie-Paule Lefranc, Panagiotis Panagiotidis, Gunnar Juliusson, Achilles Anagnostopoulos, Darko Antic, Livio Trentin, Marco Montillo, Carsten Niemann, Hartmut Döhner, MD, Anton W. Langerak, Nikos Darzentas, Sarka Pospisilova, Michael Hallek, MD, Elias Campo, Nicholas Chiorazzi, MD, David Oscier, Gianluca Gaidano, MD PhD, Chrysoula Belessi, Diane F. Jelinek, Stephan Stilgenbauer, MD, Frederic Davi, Richard Rosenquist, Paolo Ghia, Kostas Stamatopoulos

Blood (2015) 126 (23): 5263.

https://doi.org/10.1182/blood.V126.23.5263.5263

Published: 2015

Journal Articles

The Correlation of APOBEC Gene Family Member Expression with Worse CLL Patient Outcome Suggests a Role in CLL Mutational Evolution

Charles C Chu, Xiao-Jie Yan, MD PhD, Arvind Dhayalan, Piers E. Patten, BSc, MRCP, MRCPath, PhD, Thomas MacCarthy, PhD, Chaohui Yuan, MS, Jacqueline C. Barrientos, MD, Jonathan E. Kolitz, MD, Steven L Allen, MD, Kanti R. Rai, MD, Nicholas Chiorazzi, MD

Blood (2015) 126 (23): 363.

https://doi.org/10.1182/blood.V126.23.363.363

Published: 2015

Journal Articles

Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8

Maria Gounari, Stavroula Ntoufa, Benedetta Apollonio, Nikos Papakonstantinou, Maurilio Ponzoni, Charles C. Chu, Davide Rossi, Gianluca Gaidano, Nicholas Chiorazzi, Kostas Stamatopoulos, Paolo Ghia

Blood (2015) 125 (23): 3580–3587.

https://doi.org/10.1182/blood-2014-09-603217

Published: 2015

Includes: Supplemental data

Journal Articles

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

Panagiotis Baliakas, Andreas Agathangelidis, Anastasia Hadzidimitriou, Lesley-Ann Sutton, Eva Minga, Athina Tsanousa, Lydia Scarfò, Zadie Davis, Xiao-Jie Yan, Tait Shanafelt, Karla Plevova, Yorick Sandberg, Fie Juhl Vojdeman, Myriam Boudjogra, Tatiana Tzenou, Maria Chatzouli, Charles C. Chu, Silvio Veronese, Anne Gardiner, Larry Mansouri, Karin E. Smedby, Lone Bredo Pedersen, Denis Moreno, Kirsten Van Lom, Véronique Giudicelli, Hana Skuhrova Francova, Florence Nguyen-Khac, Panagiotis Panagiotidis, Gunnar Juliusson, Lefteris Angelis, Achilles Anagnostopoulos, Marie-Paule Lefranc, Monica Facco, Livio Trentin, Mark Catherwood, Marco Montillo, Christian H. Geisler, Anton W. Langerak, Sarka Pospisilova, Nicholas Chiorazzi, David Oscier, Diane F. Jelinek, Nikos Darzentas, Chrysoula Belessi, Frederic Davi, Paolo Ghia, Richard Rosenquist, Kostas Stamatopoulos

Blood (2015) 125 (5): 856–859.

https://doi.org/10.1182/blood-2014-09-600874

Published: 2015

Includes: Supplemental data

Journal Articles

TLR-9 and IL-15-Driven Clonal Expansion of B-CLL Cells

Patricia K. A. Mongini, PhD, Rashmi Gupta, PhD, Charles C. Chu, PhD, Joanna Stein, MPH, Tatjana Stankovic, MDPhD, Jacqueline C. Barrientos, MD, Jonathan E. Kolitz, MD, Steven L. Allen, MD, Kanti R. Rai, MD, Nicholas Chiorazzi, MD

Blood (2014) 124 (21): 1937.

https://doi.org/10.1182/blood.V124.21.1937.1937

Published: 2014

Journal Articles

Charting Unique Signatures of Somatic Hypermutation Amongst Chronic Lymphocytic Leukemia Patients Expressing IGHV4-34 Clonotypic B Cell Receptors

Blood (2014) 124 (21): 1969.

https://doi.org/10.1182/blood.V124.21.1969.1969

Published: 2014

Journal Articles

IGHV-D-J Ultra-Deep Sequencing Reveals APOBEC and AID Targeted Mutations during Clonal Evolution of CLL in a Xenograft Mouse Model

Charles C. Chu, PhD, Piers E.M. Patten, BSc, MRCP, MRCPath, PhD, Thomas MacCarthy, PhD, Chaohui Yuan, MS, Xiao-Jie Yan, MD PhD, Jacqueline C. Barrientos, MD, Jonathan E. Kolitz, MD, Steven L. Allen, MD, Kanti R. Rai, MD, Nicholas Chiorazzi, MD

Blood (2014) 124 (21): 300.

https://doi.org/10.1182/blood.V124.21.300.300

Published: 2014

Journal Articles

Clinical Impact of Stereotyped Antigen Receptors in Chronic Lymphocytic Leukemia

Panagiotis Baliakas, Anastasia Hadzidimitriou, Lesley-Ann Sutton, Evangelia Minga, Andreas Agathangelidis, Athina Tsanousa, Lydia Scarfo, Zadie Davis, Joy Yan, Tait D. Shanafelt, MD, Karla Plevova, M.S., PhD, Yorick Sandberg, Fie Juhl Vojdeman, Myriam Boudjoghra, Tatiana Tzenou, Maria Chatzouli, Charles C. Chu, PhD, Silvio Veronese, Anne Catherine Gardiner, Larry Mansouri, Karin E Smedby, MD PhD, Lone Pedersen, Denis Moreno, Kirsten van Lom, Veronique Giudicelli, Hana Francova, Florence Nguyen-Khac, MDPhD, Panagiotis Panagiotidis, Gunnar Juliusson, Lefteris Angelis, Achilles Anagnostopoulos, Marie-Paule Lefranc, Monica Facco, Livio Trentin, Mark Catherwood, Marco Montillo, MD, Christian H Geisler, Anton W Langerak, Sarka Pospisilova, Nicholas Chiorazzi, MD, David Oscier, Diane F. Jelinek, Nikos Darzentas, Chrysoula Belessi, Frederic Davi, MD PhD, Richard Rosenquist, Paolo Ghia, MD PhD, Kostas Stamatopoulos, on behalf of ERIC, the European Research Initiative on CLL

Blood (2014) 124 (21): 3280.

https://doi.org/10.1182/blood.V124.21.3280.3280

Published: 2014

Journal Articles

Evaluation of IGHV Ultra-Deep Sequences for Activation-Induced Deaminase Characteristics in CLL Cells after T Cell Stimulation

Charles C. Chu, PhD, Piers E.M. Patten, MD, PhD, Thomas MacCarthy, PhD, Xiao-Jie Yan, MD PhD, Jacqueline C. Barrientos, MD, Jonathan E. Kolitz, MD, Steven L. Allen, MD, Kanti R. Rai, MD, Nicholas Chiorazzi, MD

Blood (2013) 122 (21): 2583.

https://doi.org/10.1182/blood.V122.21.2583.2583

Published: 2013

Journal Articles

IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions

Piers E. M. Patten, Charles C. Chu, Emilia Albesiano, Rajendra N. Damle, Xiao-Jie Yan, Dorothy Kim, Lu Zhang, Amanda R. Magli, Jacqueline Barrientos, Jonathan E. Kolitz, Steven L. Allen, Kanti R. Rai, Sergio Roa, Patricia K. Mongini, Thomas MacCarthy, Matthew D. Scharff, Nicholas Chiorazzi

Blood (2012) 120 (24): 4802–4811.

https://doi.org/10.1182/blood-2012-08-449744

Published: 2012

Includes: Supplemental data

NARROW

Low Dose Rituximab Efficiently Clears Circulating CLL Cells and Maintains Sensitivity to Antibody Dependent Cellular Phagocytosis (ADCP)

Splenic B Cell Lymphoma Innate Immune Cells: Detection of Red Versus White Pulp Lymphoma Differences in NK Cell Populations By High-Parameter Flow Cytometry

Rituximab Induces an Inflammatory Cytokine Response with Increased IP-10 (CXCR10) in Patients with Infusion Reactions

Innate Immune Microenvironment of Indolent B Cell Splenic Lymphomas: Role in Diagnosis and Treatment

Rapid Tumor Debulking of Relapsed/Refractory CLL Patients By PI3Kδ Inhibition and Anti-CD20 Monoclonal Antibody Treatment

Characterizing Naked Nuclei Frequency and Movement in Primary AML Cell Culture Using an ECM-Based Model

Ibrutinib Off-Target Inhibition Inhibits Antibody-Dependent Cellular Phagocytosis but Not Efferocytosis of CLL Cells

Macrophage hypophagia as a mechanism of innate immune exhaustion in mAb-induced cell clearance

Anti-CD20 Therapy Reliance on Antibody-Dependent Cellular Phagocytosis Affects Combination Drug Choice

CLL Stereotyped Subset #4 Igs Acquire Binding to Viable B Lymphocyte Surfaces By Somatic Mutations, Isotype Class Switching, and with the Prerequisite of IG Self-Association

CLL with Mutated IGHV4-34 Antigen Receptors Is Clinically Heterogeneous: Antigen Receptor Stereotypy Makes the Difference

The Correlation of APOBEC Gene Family Member Expression with Worse CLL Patient Outcome Suggests a Role in CLL Mutational Evolution

Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8

Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations

TLR-9 and IL-15-Driven Clonal Expansion of B-CLL Cells

Charting Unique Signatures of Somatic Hypermutation Amongst Chronic Lymphocytic Leukemia Patients Expressing IGHV4-34 Clonotypic B Cell Receptors

IGHV-D-J Ultra-Deep Sequencing Reveals APOBEC and AID Targeted Mutations during Clonal Evolution of CLL in a Xenograft Mouse Model

Clinical Impact of Stereotyped Antigen Receptors in Chronic Lymphocytic Leukemia

Evaluation of IGHV Ultra-Deep Sequences for Activation-Induced Deaminase Characteristics in CLL Cells after T Cell Stimulation

IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only